HUNAN YIYI PHARMACEUTICAL TECHNOLOGY
HUNAN YIYI PHARMACEUTICAL TECHNOLOGY
Industry:
Health Care Pharmaceutical Therapeutics
Website Url:
http://www.onekdrug.com
Status:
Active
Contact:
400-900-5120
Total Funding:
0
Investors List
Unicorn Capital Partners
Unicorn Capital Partners investment in Series B - Hunan Yiyi Pharmaceutical Technology
Cenova
Cenova investment in Series B - Hunan Yiyi Pharmaceutical Technology
CBC Group
CBC Group investment in Series B - Hunan Yiyi Pharmaceutical Technology
Official Site Inspections
http://www.onekdrug.com
- Host name: 39.108.85.159
- IP address: 39.108.85.159
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Hunan Yiyi Pharmaceutical Technology"
onekdrug.com - 一块医药 天天药惊喜
一块医药一家专业的医药B2B平台，一块医药网上交易采购平台，品种齐全，100%正品，安全放心,安全便捷，药品采购就上一块医药，医药人自己的电商平台，每天给你新惊喜!See details»
Onekdrug 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Onekdrug. Use the PitchBook Platform to explore the full profile.See details»
One K Drug - Products, Competitors, Financials, Employees, …
About One K Drug One K Drug operates a business-to-business pharmaceutical e-commerce platform operating in the healthcare sector. It offers a marketplace for healthcare professionals …See details»
Wholesale Pharmaceutical Technology Co., Ltd湖南一块医药科技 …
Feb 15, 2023 See how Wholesale Pharmaceutical Technology Co., Ltd湖南一块医药科技有限公司 is helping create the world we all wantSee details»
Onekdrug Raises Series B+ Funding to Boost Pharmaceutical B2B …
Aug 31, 2022 Company Profile Onekdrug, a B2B pharmaceutical e-commerce platform, focuses on emerging chain and single-store pharmacies. It connects upstream manufacturers with …See details»
Hunan Yiyi Pharmaceutical Technology - Crunchbase
Hunan Yiyi Pharmaceutical Technology develops and operates an online platform for pharmaceutical products. It allows members to purchase various medicines. Hunan Yiyi Pharmaceutical Technology was founded in 2019 and is based in …See details»
企业简介 - 湖南一块医药科技有限公司
一块医药拥有强大的采购网络，已与1000+家制药企业建立战略伙伴关系，涵盖1000+个自有品牌；累计服务超过1800+家连锁企业、70000+家区县连锁药房。See details»
一块医药·药房经营更轻松
Jun 13, 2025 地点：湖南省长沙县湘龙街道湘绣社区腾辉路70号See details»
一块医药-湖南空间折叠互联网科技有限公司-企业详情-InvestGO数 …
Dec 25, 2017 查看医药魔方InvestGO®数据库一块医药的公司信息。一块医药（湖南空间折叠互联网科技有限公司），公司简介：一块医药瞄准下沉市场中小连锁、单体药店，旨在连接上游 …See details»
湖南一块医药科技有限公司_百度百科
湖南一块医药科技有限公司于2019年03月01日成立，隶属于 湖南空间折叠互联网科技有限公司 全资子公司。公司经营范围包括：医药学术推广服务；中医药推广；中医药文化推广；医疗信息、技术咨询服务；医疗器械技术转让服务；医疗 …See details»
Onekdrug Archives - Insight, China's Pharmaceutical Industry
Explore the latest insights on Onekdrug and its impact on China's pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the …See details»
Document - onekdrug.com
2、您只能通过您的密码来使用您的账号。如果您忘记或丢失了密码或者您的个人识别信息，将可能危及您的账号安全，并可能对您的人身和财产安全造成不利后果。因此，无论任何原因危及 …See details»
一块医药 - 药品药学 - 堆扎网
一块医药 于2019年初成立，致力于搭建链接产业上下游、覆盖区域性中小连锁、单体药店的医药B2B供应链+运营一体化赋能平台。一块医药打通工厂和零售终端，依托顶级供应链资源，形 …See details»
36氪首发 | 持续加码供应链和推动药房连锁化，B2B医药平台「一 …
不只是撮合交易。36氪获悉，药房运营服务商 “一块医药” 已完成数千万美元B+轮融资。本轮融资由CBC康桥资本领投，老股东千骥资本和独秀资本跟 ...See details»
医药 B2B 供应链平台一块医药完成数千万元 A 轮融资 - 动点科技
Oct 27, 2020 医药 B2B 供应链平台一块医药完成 数千万元 A 轮融资。本轮融资由红杉中国种子基金领投，心元资本、梅花天使创投、德迅投资跟投。资金将主要用于加强供应链能力、研发 …See details»
OneDrug
Our primary objective is to enable personalized precision medicine on a global scale. OneDrug is a pioneering medical technology startup focused on advancing precision medicine for better …See details»
湖南一块医药科技有限公司 - 一块医药 - 爱企查
简介： 1、基本情况 湖南一块医药科技有限公司成立于2019年03月01日，位于湖南省长沙县湘龙街道湘绣社区腾辉路70号综合楼101室，目前处于开业状态，经营范围包括一般事项：医学研 …See details»
Hunan Wholesale Pharmaceutical Technology Co., Ltd.
了解Hunan Wholesale Pharmaceutical Technology Co., Ltd.公司的药物管线，治疗领域，技术平台，以及它的。See details»
Ozempic approved in Canada to slow kidney decline, prevent ...
15 hours ago Diabetic medicine Ozempic now approved by Health Canada to reduce the risk of further kidney decline among patients with Type 2 diabetes.See details»
Canada approves Ozempic to cut risk of kidney failure, heart …
23 hours ago Canada has approved Novo Nordisk's diabetes drug, Ozempic, to cut chronic kidney disease progression and reduce the risk of kidney failure and heart-related deaths in …See details»